NSE: ASTERDM | BSE: 540975

Mid-range Performer

Download real time

558.80 -12.60 (-2.21%)

High volume today

NSE 20 Jun, 2025 3:31 PM (IST)

28,952.6

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Aster DM Healthcare Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ASTERDM, BSE:540975 Aster DM Healthcare Ltd.

Aster DM Healthcare Ltd.

16 Aug 2022

558.80

-2.21%

Margin miss; healthy outlook

Accumulate: Aster DM Healthcare Ltd.

Recommendation Target

ICICI Securities Limited

Aster DM Healthcare’s (Aster) Q1FY23 performance was below our estimates on profitability front.

Aster DM Healthcare Ltd. has gained 56.86% in the last 1 Year

Aster DM Healthcare Ltd.

12 Aug 2022

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

ICICI Direct

Number of FII/FPI investors increased from 208 to 227 in Mar 2025 qtr.

Aster DM Healthcare Ltd.

26 May 2022

558.80

-2.21%

ASTER DM HEALTHCARE

Buy: Aster DM Healthcare Ltd.

Prabhudas Lilladhar

Aster DM Healthcare Ltd. is trading below its 30 day SMA of 565.7

Aster DM Healthcare Ltd.

10 Feb 2022

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

ICICI Securities Limited

Revenue break-up 9MFY22: hospitals: 56%, pharmacies: 21%, clinics: 23% with GCC & India contributing 76% & 24% of revenues, respectively Q3FY22 Results: Good numbers driven by significant improvement in footfalls...

Aster DM Healthcare .. has an average target of 620.00 from 1 broker.

Aster DM Healthcare Ltd.

13 Nov 2021

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

Target

ICICI Securities Limited

...

Aster DM Healthcare Ltd. has gained 28.92% in the last 3 Months

Aster DM Healthcare Ltd.

13 Aug 2021

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

Target

ICICI Securities Limited

...

Number of FII/FPI investors increased from 208 to 227 in Mar 2025 qtr.

Aster DM Healthcare Ltd.

10 Feb 2021

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

Target

ICICI Securities Limited

Strong RoCE in GCC despite aggressive expansion Aster derives ~81% of revenues from GCC countries. In the last six years, it expanded its hospitals, clinics, pharmacy count by ~2x. However, despite aggressive expansion, RoCE stayed healthy [hospitals- 12% (established hospitals- 25%), clinics- 21% and pharmacies- 44%] due to 1) asset light model, 2) integrated business model, 3) faster occupancy owing to strong brand equity, 4) healthy ARPOB and 5) targeted strategy. We believe RoCE would improve further due to continuing improvement in occupancy,...

Aster DM Healthcare Ltd. is trading above its 200 day SMA of 474.0

Aster DM Healthcare Ltd.

25 Jun 2020

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

Target

ICICI Securities Limited

Q4FY20 revenues grew 4.6% YoY to | 2301 crore. EBITDA margins expanded 163 bps YoY to 17.6% mainly due to lower other expenses on Ind-AS adjustment. Subsequent EBITDA grew 15.3% YoY to | 404 crore. However, PAT fell 37.4% YoY to | 131 crore. Delta vis-a-vis EBITDA was mainly due to higher interest & depreciation expenses due to Ind-AS 116....

Aster DM Healthcare Ltd.'s price crossed below 30Day SMA today

Aster DM Healthcare Ltd.

10 Dec 2019

558.80

-2.21%

Aster DM Healthcare

Buy: Aster DM Healthcare Ltd.

ICICI Securities Limited

Strong RoCE in GCC despite aggressive expansion Aster derives ~81% of revenues from GCC countries. In the last six years, the company has expanded its hospitals, clinics and pharmacy count by almost 2x. However, despite aggressive expansion, the RoCE has remained healthy (hospitals- 13% (established hospitals - 27%), clinics - 25% and pharmacies - 45%) due to 1) asset light model, 2) integrated business model, 3) faster occupancy owing to strong brand equity, 4) healthy ARPOB and 5) targeted strategy. We believe RoCE will improve further due to continuing...

Aster DM Healthcare .. has an average target of 620.00 from 1 broker.

Is Aster DM Healthcare Ltd. worth buying?

520 Votes:

Buy 76.15%

Sell 11.15%

Hold 12.69%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf